Detailed price information for Arbutus Biopharma Corp (ABUS-Q) from The Globe and Mail including charting and trades.

Arbutus (ABUS) delivered earnings and revenue surprises of +150.00% and +496.61%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Arbutus Biopharma Corp. ABUS) on Wednesday reported second-quarter net income of $2.5 million, after reporting a loss in the ...